Search research articles
Contact Us
Filters
Showing results (121-130 of 234) with videos related to
Page
of 24
Sort By:
Schizophrenia Research
|
June 24, 2020
Catatonia in a patient with Aicardi-Goutières syndrome efficiently treated with immunoadsorption
Anaël Ayrolles, Pierre Ellul, Florence Renaldo, et al.
Neurology
|
February 15, 2013
Elevation of proinflammatory cytokines in patients with Aicardi-Goutières syndrome
Asako Takanohashi, Morgan Prust, Jichuan Wang, et al.
Plos One
|
December 3, 2015
ADAR1 Facilitates HIV-1 Replication in Primary CD4+ T Cells
Eloy Cuadrado, Thijs Booiman, John L van Hamme, et al.
Kidney International Reports
|
August 24, 2019
COPA Syndrome as a Cause of Lupus Nephritis
Siham Boulisfane-El Khalifi, Sebastien Viel, Annie Lahoche, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 21, 2017
Brief Report: Blockade of TANK-Binding Kinase 1/IKKɛ Inhibits Mutant Stimulator of Interferon Genes (STING)-Mediated Inflammatory Responses in Human Peripheral Blood Mononuclear Cells
Marie-Louise Frémond, Carolina Uggenti, Lien Van Eyck, et al.
Journal of Clinical Immunology
|
December 13, 2016
Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease
Gillian I Rice, Isabelle Melki, Marie-Louise Frémond, et al.
Brain & Development
|
October 27, 2021
Autosomal dominant ADAR c.3019G>A (p.(G1007R)) variant is an important mimic of hereditary spastic paraplegia and cerebral palsy
Hannah F Jones, Marion Stoll, Gladys Ho, et al.
Clinical & Translational Immunology
|
June 30, 2026
Early brain-penetrant immunotherapy reverses interferon signature and improves motor outcome in a case of ADAR1-related Aicardi-Goutières syndrome
Russell C Dale, Jessica Hayes, Velda X Han, et al.
Nature Genetics
|
October 2, 2002
ASPM is a major determinant of cerebral cortical size
Jacquelyn Bond, Emma Roberts, Ganesh H Mochida, et al.
Rheumatology (Oxford, England)
|
October 31, 2019
Inhibition of IFNα secretion in cells from patients with juvenile dermatomyositis under TBK1 inhibitor treatment revealed by single-molecular assay technology
Cyril Gitiaux, Vincent Bondet, Nassima Bekaddour, et al.
Page
of 24
Search research articles
Search
Showing results (121-130 of 234) with videos related to
Sort By:
Page
of 24
Schizophrenia Research
|
June 24, 2020
Catatonia in a patient with Aicardi-Goutières syndrome efficiently treated with immunoadsorption
Anaël Ayrolles, Pierre Ellul, Florence Renaldo, et al.
Neurology
|
February 15, 2013
Elevation of proinflammatory cytokines in patients with Aicardi-Goutières syndrome
Asako Takanohashi, Morgan Prust, Jichuan Wang, et al.
Plos One
|
December 3, 2015
ADAR1 Facilitates HIV-1 Replication in Primary CD4+ T Cells
Eloy Cuadrado, Thijs Booiman, John L van Hamme, et al.
Kidney International Reports
|
August 24, 2019
COPA Syndrome as a Cause of Lupus Nephritis
Siham Boulisfane-El Khalifi, Sebastien Viel, Annie Lahoche, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 21, 2017
Brief Report: Blockade of TANK-Binding Kinase 1/IKKɛ Inhibits Mutant Stimulator of Interferon Genes (STING)-Mediated Inflammatory Responses in Human Peripheral Blood Mononuclear Cells
Marie-Louise Frémond, Carolina Uggenti, Lien Van Eyck, et al.
Journal of Clinical Immunology
|
December 13, 2016
Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease
Gillian I Rice, Isabelle Melki, Marie-Louise Frémond, et al.
Brain & Development
|
October 27, 2021
Autosomal dominant ADAR c.3019G>A (p.(G1007R)) variant is an important mimic of hereditary spastic paraplegia and cerebral palsy
Hannah F Jones, Marion Stoll, Gladys Ho, et al.
Clinical & Translational Immunology
|
June 30, 2026
Early brain-penetrant immunotherapy reverses interferon signature and improves motor outcome in a case of ADAR1-related Aicardi-Goutières syndrome
Russell C Dale, Jessica Hayes, Velda X Han, et al.
Nature Genetics
|
October 2, 2002
ASPM is a major determinant of cerebral cortical size
Jacquelyn Bond, Emma Roberts, Ganesh H Mochida, et al.
Rheumatology (Oxford, England)
|
October 31, 2019
Inhibition of IFNα secretion in cells from patients with juvenile dermatomyositis under TBK1 inhibitor treatment revealed by single-molecular assay technology
Cyril Gitiaux, Vincent Bondet, Nassima Bekaddour, et al.
Page
of 24